Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 11-12/2002

01-12-2002 | Original Article

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

Authors: Angela Märten, Dimitri Flieger, Sabine Renoth, Silvia Weineck, Peter Albers, Markus Compes, Björn Schöttker, Carsten Ziske, Steffen Engelhart, Peter Hanfland, Ludmila Krizek, Cora Faber, Alexander von Ruecker, Stefan Müller, Tilman Sauerbruch, Ingo G. Schmidt-Wolf

Published in: Cancer Immunology, Immunotherapy | Issue 11-12/2002

Login to get access
Metadata
Title
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial
Authors
Angela Märten
Dimitri Flieger
Sabine Renoth
Silvia Weineck
Peter Albers
Markus Compes
Björn Schöttker
Carsten Ziske
Steffen Engelhart
Peter Hanfland
Ludmila Krizek
Cora Faber
Alexander von Ruecker
Stefan Müller
Tilman Sauerbruch
Ingo G. Schmidt-Wolf
Publication date
01-12-2002
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 11-12/2002
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-002-0324-0

Other articles of this Issue 11-12/2002

Cancer Immunology, Immunotherapy 11-12/2002 Go to the issue

Original Article

Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody

Symposium Series

Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002

Original Article

Linomide administration following bone marrow transplantation in mice

Original Article

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Original Article

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

Original Article

41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits